BSE filing, NSE: TITANBIO. Summary written from the filing by ALFA Finder's alert engine.
Titan Biotech Ltd: key numbers
- Share price
- ₹352.00
- Market cap
- ₹1,818 Cr
- Revenue (annual)
- ₹206.2 Cr
- Net profit (annual)
- ₹29.89 Cr
- P/E (TTM)
- 53.7×Sector 34.1×
- Promoter holding
- 55.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Titan Biotech Ltd
All →Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Titan Biotech Other Announcement
Titan Biotech Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Titan Biotech Bonus Issue
Titan Biotech Ltd fixed October 23, 2026, as the record date for its 1:4 bonus share issue. Allotment is scheduled for October 26, 2026.
Titan Biotech Capital Structure Change
Titan Biotech increased its authorised share capital from Rs. 10 Crore to Rs. 10.40 Crore, following shareholder approval at the 34th Annual General Meeting.
Titan Biotech Annual General Meeting
Titan Biotech Limited held its 34th Annual General Meeting on September 29, 2026. The meeting transacted ordinary and special business, including financial adoption and director appointments.
Titan Biotech Annual Report
Titan Biotech filed its 34th Annual Report and AGM Notice for the financial year 2025-26. The AGM is scheduled for September 29, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.